(Q39327809)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

NFATc2 is a potential therapeutic target in human melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Elena Tassi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Riccardo Dolcetti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andrea Anichini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jessica Dal Col

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Roberta Mortarini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Paola Baldassari

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ilaria Bersani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alessandra Molla

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Claudia Vegetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

21 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

2652-2660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

Ion channel phenotype of melanoma cell lines

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Cyclosporine A and its non-immunosuppressive derivative NIM811 induce apoptosis of malignant melanoma cells in in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

BRAF alterations are associated with complex mutational profiles in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Functional genomics of calcium channels in human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Systematic review of medical treatment in melanoma: current status and future prospects.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Caspase 2-mediated tumor suppression involves survivin gene silencing

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

NFAT proteins: emerging roles in cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Mechanisms of disease: Inflammatory mediators and cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Caspase-2 activation in the absence of PIDDosome formation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

The calcineurin/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Mutant BRAF melanomas--dependence and resistance

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

The Birc6 (Bruce) gene regulates p53 and the mitochondrial pathway of apoptosis and is essential for mouse embryonic development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Caspase-2 is required for DNA damage-induced expression of the CDK inhibitor p21(WAF1/CIP1)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Calcineurin signaling regulates human islet {beta}-cell survival.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.179

7 January 2021

Identifiers

DOI

10.1038/JID.2012.179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718120%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference